Early-Pregnancy Cytokines in Mothers to Children Developing Multiple, Persistent Islet Autoantibodies, Type 1 Diabetes, or Both Before 7Years of Age

American Journal of Reproductive Immunology

Volumn 66, Issue 6, 2011, Pages 495-503

  Lindehammer, Sabina Resic ^a   Fex, Malin ^a   Maziarz, Marlena ^b   Hanson, Ida ^a   Maršál, Karel ^a   Lernmark, Åke ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmunity; Cytokines; Human; Pregnancy; Th1 Th2 response

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; HLA DQ ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GESTATION PERIOD; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON GAMMA RELEASE ASSAY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PARITY; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AUTOANTIBODIES; AUTOIMMUNITY; CHILD; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-2; ISLETS OF LANGERHANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RISK FACTORS; TH1 CELLS; YOUNG ADULT;

EID: 81155152482     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01057.x     Document Type: Article

References (64)

1. Gale EA: The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51:3353-3361.
2. Pundziute-Lycka A, Dahlquist G, Nystrom L, Arnqvist H, Bjork E, Blohme G, Bolinder J, Eriksson JW, Sundkvist G, Ostman J: The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34years group in Sweden 1983-1998. Diabetologia 2002; 45:783-791.
3. Charkaluk ML, Czernichow P, Levy-Marchal C: Incidence data of childhood-onset type I diabetes in France during 1988-1997: the case for a shift toward younger age at onset. Pediatr Res 2002; 52:859-862.
4. Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B: TEDDY - The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann N Y Acad Sci 2006; 1079:320-326.
5. Menser MA, Dods L, Harley JD: A twenty-five-year follow-up of congenital rubella. Lancet 1967; 2:1347-1350.
6. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M: Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 1995; 44:408-413.
7. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T et al.: A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995; 44:652-657.
8. Dahlquist G, Kallen B: Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:671-675.
9. McKinney PA, Parslow R, Gurney K, Law G, Bodansky HJ, Williams DR: Antenatal risk factors for childhood diabetes mellitus; a case-control study of medical record data in Yorkshire, UK. Diabetologia 1997; 40:933-939.
10. Eising S, Nilsson A, Carstensen B, Hougaard DM, Norgaard-Pedersen B, Nerup J, Lernmark A, Pociot F: Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes. Eur J Endocrinol 2011; 164:247-252.
11. Patterson CC, Carson DJ, Hadden DR, Waugh NR, Cole SK: A case-control investigation of perinatal risk factors for childhood IDDM in Northern Ireland and Scotland. Diabetes Care 1994; 17:376-381.
12. Bingley PJ, Douek IF, Rogers CA, Gale EA: Influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study. Bart's-Oxford Family Study Group. BMJ 2000; 321:420-424.
13. Bock T, Pedersen CR, Volund A, Pallesen CS, Buschard K: Perinatal determinants among children who later develop IDDM. Diabetes Care 1994; 17:1154-1157.
14. Dahlquist G, Bennich SS, Kallen B: Intrauterine growth pattern and risk of childhood onset insulin dependent (type I) diabetes: population based case-control study. BMJ 1996; 313:1174-1177.
15. Metcalfe MA, Baum JD: Family characteristics and insulin dependent diabetes. Arch Dis Child 1992; 67:731-736.
16. Stene LC, Magnus P, Lie RT, Sovik O, Joner G: Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 2001; 322:889-892.
17. Larsson HE, Hansson G, Carlsson A, Cederwall E, Jonsson B, Larsson K, Lynch K, Neiderud J, Lernmark A, Ivarsson SA: Children developing type 1 diabetes before 6years of age have increased linear growth independent of HLA genotypes. Diabetologia 2008; 51:1623-1630.
18. Khan N, Couper JJ: Low-birth-weight infants show earlier onset of IDDM. Diabetes Care 1994; 17:653-656.
19. Larsson HE, Lynch K, Lernmark B, Hansson G, Lernmark A, Ivarsson SA: Relationship between increased relative birthweight and infections during pregnancy in children with a high-risk diabetes HLA genotype. Diabetologia 2007; 50:1161-1169.
20. Dahlquist GG, Boman JE, Juto P: Enteroviral RNA and IgM antibodies in early pregnancy and risk for childhood-onset IDDM in offspring. Diabetes Care 1999; 22:364-365.
21. Viskari HR, Roivainen M, Reunanen A, Pitkaniemi J, Sadeharju K, Koskela P, Hovi T, Leinikki P, Vilja P, Tuomilehto J, Hyoty H: Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes 2002; 51:2568-2571.
22. Zav'ialov VP: [The structural and functional classification and evolution of cytokines]. Vestn Ross Akad Med Nauk 1993; 2:8-10.
23. Commins SP, Borish L, Steinke JW: Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 2010; 125:S53-S72.
24. Dinarello CA: Historical insights into cytokines. Eur J Immunol 2007; 37(Suppl 1):S34-S45.
25. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14:353-356.
26. Saito S: Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47:87-103.
27. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
28. Wilczynski JR: Th1/Th2 cytokines balance - yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol 2005; 122:136-143.
29. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J: TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 2004; 134:93-119.
30. Athanassakis I, Vassiliadis S: Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy. Immunology 2002; 107:281-287.
31. Mikloska Z, Cunningham AL: Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J Virol 2001; 75:11821-11826.
32. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15:749-795.
33. Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19:65-91.
34. Smith KA: Interleukin-2: inception, impact, and implications. Science 1988; 240:1169-1176.
35. Chen SH, Oakes JE, Lausch RN: Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Antiviral Res 1993; 22:15-29.
36. Trinchieri G: Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993; 14:335-338.
37. Malmgaard L, Paludan SR: Interferon (IFN)-alpha/beta, interleukin (IL)-12 and IL-18 coordinately induce production of IFN-gamma during infection with herpes simplex virus type 2. J Gen Virol 2003; 84:2497-2500.
38. Gery I, Gershon RK, Waksman BH: Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med 1972; 136:128-142.
39. Street NE, Mosmann TR: Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5:171-177.
40. van Roon JA, Bijlsma JW: Th2 mediated regulation in RA and the spondyloarthropathies. Ann Rheum Dis 2002; 61:951-954.
41. Hagiwara E, Gourley MF, Lee S, Klinman DK: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996; 39:379-385.
42. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW: Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102:20-25.
43. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
44. Otonkoski T, Roivainen M, Vaarala O, Dinesen B, Leipala JA, Hovi T, Knip M: Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000; 43:1235-1238.
45. Ryding J, French KM, Naucler P, Barnabas RV, Garnett GP, Dillner J: Seroepidemiology as basis for design of a human papillomavirus vaccination program. Vaccine 2008; 26:5263-5268.
46. Lernmark B, Elding-Larsson H, Hansson G, Lindberg B, Lynch K, Sjoblad S: Parent responses to participation in genetic screening for diabetes risk. Pediatr Diabetes 2004; 5:174-181.
47. Larsson HE, Lynch K, Lernmark B, Nilsson A, Hansson G, Almgren P, Lernmark A, Ivarsson SA: Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 2005; 48:1484-1491.
48. Lynch KF, Lernmark B, Merlo J, Cilio CM, Ivarsson SA, Lernmark A: Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype. J Perinatol 2008; 28:211-217.
49. Lindehammer SR, Hansson I, Midberg B, Ivarsson SA, Lynch KF, Dillner J, Lernmark A: Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers. J Reprod Immunol 2010; 88:72-79.
50. Lindehammer SR, Hansson I, Midberg B, Ivarsson SA, Lynch KF, Dillner J, Lernmark A: Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers. J Reprod Immunol 2011; 88:72-79.
51. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B: Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85:843-848.
52. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS: Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008; 17:3450-3456.
53. Gogos CA, Drosou E, Bassaris HP, Skoutelis A: Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000; 181:176-180.
54. Ashkar AA, Di Santo JP, Croy BA: Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192:259-270.
55. Fukushima K, Miyamoto S, Tsukimori K, Kobayashi H, Seki H, Takeda S, Kensuke E, Ohtani K, Shibuya M, Nakano H: Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol Reprod 2005; 73:172-179.
56. Veith GL, Rice GE: Interferon gamma expression during human pregnancy and in association with labour. Gynecol Obstet Invest 1999; 48:163-167.
57. Opsjln SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R: Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169:397-404.
58. Hill JA, Polgar K, Anderson DJ: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995; 273:1933-1936.
59. Daher S, de Arruda Geraldes Denardi K, Blotta MH, Mamoni RL, Reck AP, Camano L, Mattar R: Cytokines in recurrent pregnancy loss. J Reprod Immunol 2004; 62:151-157.
60. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, Morikawa H: Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 1999; 41:297-306.
61. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW: Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82:4196-4200.
62. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V: Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000; 12:1712-1716.
63. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR: Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992; 153:115-124.
64. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL: Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999; 6:89-95.